Careers  |   Log In  |   Register  |   Welcome Center  |   Follow Us  Facebook  Twitter Google Plus

Latest in Allergy & Clinical Immunology

Reuters Health • The Doctor's Channel Daily Newscast

Abatacept improves quality of life of children with juvenile arthritis

NEW YORK (Reuters Health) – Children and adolescents with juvenile idiopathic arthritis who have a clinical response to treatment with the biologic agent abatacept experience a significant improvement in their health-related quality of life (HRQoL),...

Reuters Health • The Doctor's Channel Daily Newscast

Use of steroids in treating anaphylaxis questioned

NEW YORK (Reuters Health) –There’s no reliable evidence to support or refute the use of glucocorticoids for treating anaphylaxis, despite recommendations found in several guidelines, according to the results of a Cochrane systematic review. “We...

Reuters Health • The Doctor's Channel Daily Newscast

Benefits of early aggressive RA treatment extend over long-term

NEW YORK (Reuters Health) – Treating rheumatoid arthritis aggressively in the early stages, aiming for remission, produces good outcomes that are maintained for at least a decade- this according to a report published in Arthritis Research &...